Un­der new lead­er­ship, No­var­tis' San­doz unit breaks up with dig­i­tal ther­a­peu­tics out­fit Pear

Looks like No­var­tis’ San­doz unit — un­der new lead­er­ship — has sev­ered ties with Pear Ther­a­peu­tics, dis­solv­ing the part­ner­ship that was inked in 2018.

Last year, San­doz …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.